Northern Trust Corp Singular Genomics Systems, Inc. Transaction History

Northern Trust Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.78 - $1.28 $317,371 - $520,814	-406,886 Reduced 83.51%	80,363 $66,000
Q1 2023 May 15, 2023	BUY	$1.1 - $2.95 $14,063 - $37,715	12,785 Added 2.69%	487,249 $589,000
Q4 2022 Feb 13, 2023	SELL	$1.82 - $2.71 $12,801 - $19,062	-7,034 Reduced 1.46%	474,464 $953,000
Q3 2022 Nov 14, 2022	BUY	$2.5 - $4.73 $177,580 - $335,981	71,032 Added 17.31%	481,498 $1.2 Million
Q2 2022 Aug 12, 2022	BUY	$2.86 - $6.44 $131,176 - $295,377	45,866 Added 12.58%	410,466 $1.57 Million
Q1 2022 May 13, 2022	BUY	$5.94 - $12.09 $1.4 Million - $2.85 Million	235,698 Added 182.85%	364,600 $2.3 Million
Q4 2021 Feb 08, 2022	BUY	$10.45 - $16.9 $260,560 - $421,384	24,934 Added 23.98%	128,902 $1.49 Million
Q3 2021 Nov 15, 2021	BUY	$10.9 - $27.63 $1.13 Million - $2.87 Million	103,968 New	103,968 $1.16 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.4B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.